Claude

IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

IntuitionLabs
Veeva Vault Safety validation, 21 CFR Part 11 compliance, and inspection readiness for pharmacovigilance

Veeva Vault Safety Validation & Compliance

Risk-based GAMP 5 computer system validation for Veeva Vault Safety, mapped to 21 CFR Part 11, EU Annex 11, and EU GVP — including gateway qualification, migration verification, and inspection readiness for pharmacovigilance.

Our Veeva Vault Safety Validation Services

IntuitionLabs delivers risk-based computer system validation for Veeva Vault Safety that is proportionate, inspection-ready, and aligned to GAMP 5 — covering the core system, gateways, migrations, and AI-enabled workflows.

Strategy
Validation Planning
A risk-based validation plan and strategy that leverages Veeva's supplier evidence and focuses effort on your configuration, gateways, and intended use rather than re-testing the platform.
Specifications
Requirements & Risk Assessment
User requirements, functional and configuration specifications, and a documented risk assessment that drives where and how deeply you test.
Testing
IQ / OQ / PQ Execution
Risk-based test protocols and scripts with full traceability from requirement to evidence, including negative testing on critical case-processing paths.
Integration
Gateway & Interface Qualification
Conformance and acknowledgment testing for FDA, EMA, MHRA, and PMDA E2B gateways and for custom integrations to RIM, Quality, and partners.
Migration
Data Migration Verification
Field-level reconciliation and a migration verification report proving legacy cases moved completely and accurately with preserved reportability and audit history.
Lifecycle
Periodic Review & Release Control
Ongoing impact assessments and regression testing for Veeva's twice-yearly releases, keeping the system in a continuous state of control.

Risk-Based, Not Box-Ticking

The GAMP 5 Second Edition and the FDA's Computer Software Assurance guidance both push the same idea: apply critical thinking and concentrate testing where patient-safety and data-integrity risk is greatest. For Vault Safety, that means leaning on Veeva's supplier validation for the platform and focusing your effort on reportability logic, gateways, migrations, and integrations. The result is a leaner, more defensible package — less paperwork that proves little, more evidence that matters.
Risk-based validation strategy focusing test effort on high-risk pharmacovigilance functions

A Harmonized Control Matrix for FDA and EU

Rather than maintaining separate compliance evidence for each region, we build a single control matrix that maps 21 CFR Part 11 and EU Annex 11 requirements to specific Vault Safety controls — audit trail, electronic signatures, access security, and record retention. This harmonized approach supports both FDA and EU inspections from one coherent evidence set, and it makes clear which controls are met by the platform, by configuration, and by your procedures.
Harmonized 21 CFR Part 11 and EU Annex 11 control matrix for Veeva Vault Safety

Validation That Survives an Inspection

A validation package is only as good as the story it tells an inspector. We build full traceability from intended use to test evidence, document migration and gateway qualification, and prepare the SOPs and narrative your team needs when the FDA, EMA, or MHRA arrives. Pharmacovigilance systems are inspected often, so we design every artifact to stand up to scrutiny rather than to merely satisfy an internal checklist.
Inspection-ready validation documentation for a Veeva Vault Safety pharmacovigilance system

The Vault Safety Validation Package We Deliver

Each engagement produces a complete, traceable validation deliverable set aligned to GAMP 5 and your quality management system, ready for regulatory inspection.

Validation Plan & Strategy

Defines scope, GAMP 5 categorization, the leveraging of Veeva supplier evidence, roles, and the risk-based test strategy for the system, gateways, and integrations.

GAMP 5

URS & Configuration Spec

User requirements and the functional and configuration specifications that define intended use, reportability rules, coding setup, and gateway configuration.

ICH E2B

Risk Assessment & Traceability

A documented risk assessment and a traceability matrix linking every requirement to a test and to the relevant 21 CFR Part 11 and Annex 11 control.

Part 11

IQ / OQ / PQ Protocols

Risk-based installation, operational, and performance qualification protocols and scripts with executed evidence and deviation management.

CSA Guidance

Migration Verification Report

Field-level reconciliation evidence proving legacy cases migrated completely and accurately, aligned to ALCOA+ and MHRA data integrity expectations.

Data Integrity

SOPs & Periodic Review

Administration, change-control, periodic-review, and incident SOPs, plus the release-impact process that keeps the system validated through Veeva's updates.

EU GVP

Regulatory Frameworks We Validate Against

📋

21 CFR Part 11

Electronic records and signatures controls mapped to Vault Safety audit trail, e-signatures, and access security. See the eCFR Part 11.

💊

21 CFR 314.80

Postmarketing adverse drug experience reporting per 21 CFR 314.80, validated through gateway and reportability testing.

🇪🇺

EU Annex 11

Computerised systems expectations under EudraLex Volume 4 Annex 11 for EU operations.

🛡️

EU GVP

Good Pharmacovigilance Practices modules per the EMA GVP framework, including system and QMS expectations.

✅

ISPE GAMP 5

Risk-based, Category 4/5 validation aligned to the GAMP 5 Second Edition guide and CSA principles.

🔒

ALCOA+ Data Integrity

Data integrity across migration, gateways, and AI workflows aligned to MHRA GxP data integrity guidance.

Why IntuitionLabs for Vault Safety Validation

Validating a pharmacovigilance system demands more than a CSV template. It requires people who understand both the Vault platform and the regulatory weight that safety data carries — and who can validate the AI and integrations modern PV now depends on.

Platform + PV Expertise

We know Vault configuration and the GVP, E2B, and reportability rules that drive validation scope.

CSA-Aligned Efficiency

Risk-based, critical-thinking validation that leverages Veeva supplier evidence to cut needless testing.

AI & Integration Validation

We validate gateways, migrations, and governed AI workflows — not just the out-of-box screens.

Vault Safety Validation Frequently Asked Questions

Veeva Vault Safety is a GxP system: it manages the individual case safety reports and aggregate reports that support regulatory decisions about a product's benefit-risk profile, so its records and electronic signatures fall under 21 CFR Part 11 in the US and EU Annex 11 in Europe. Validation provides documented evidence that the system performs as intended, that data integrity is maintained, and that the audit trail is reliable. Pharmacovigilance systems are also a frequent focus of regulatory inspections, where a missing or weak validation package is a serious finding. We deliver validation that is both inspection-ready and proportionate to risk, following ISPE GAMP 5.
As a configurable, multi-tenant SaaS product, Vault Safety is generally treated as a GAMP 5 Category 4 (configured) system, with any custom integrations or extensions handled as Category 5. The GAMP 5 Second Edition reinforces a risk-based, critical-thinking approach: you should not re-test what Veeva has already verified, but instead focus validation effort on your configuration, your gateways and integrations, and your intended use. We leverage Veeva's per-release validation package as supplier evidence and concentrate testing where patient-safety and data-integrity risk is highest, consistent with the FDA's Computer Software Assurance guidance.
A typical Vault Safety validation package includes a validation plan, a user requirements specification, a functional and configuration specification, a risk assessment, a traceability matrix, IQ/OQ/PQ or risk-based test protocols and scripts, a data migration verification report, and a validation summary report. We also produce supporting SOPs for system administration, change control, periodic review, and incident management. Each requirement traces to a test and to the relevant regulatory control, so an inspector can follow the thread from intended use to objective evidence. We align the documentation set to GAMP 5 expectations and your internal quality management system.
We map each 21 CFR Part 11 requirement to a specific Vault Safety control: the audit trail to Vault's secure, computer-generated, time-stamped audit logging; electronic signatures to Vault's signature manifestations and signature-record linking; access security to role-based permissions and authentication; and record retention and copies to Vault's export and retention capabilities. We document which controls are met by the platform, which by configuration, and which by your procedures. The same exercise covers EU Annex 11, so a single, harmonized control matrix supports both US and EU inspections.
Yes — gateways and integrations are often where the real risk lives, because a misconfigured connection can cause a missed or malformed regulatory submission. We qualify each E2B transmission path, testing conformance against authority-specific rules for the FDA Gateway, PMDA Gateway, and MHRA AS2 connection, and we verify acknowledgments and error handling. For custom integrations to RIM, Quality, partner companies, or AI services, we apply Category 5 rigor with interface specifications, negative testing, and end-to-end traceability so the whole submission chain is validated, not just the database.
EU GVP sets expectations for the pharmacovigilance system and its quality management, including the validation and control of the systems used to manage safety data. Our validation evidences that Vault Safety supports GVP obligations — reliable case management, timely electronic reporting to EudraVigilance, accurate signal management, and a complete audit trail — and that the system is fit for the QPPV to rely on. We align the validation and the supporting SOPs with the relevant GVP modules so the system, the process, and the documentation tell one consistent story to an EU inspector.
Migration validation is a distinct, high-stakes workstream. Beyond migrating the cases, we must prove that every record moved completely and accurately, preserving reportability status and audit history. We define migration requirements and acceptance criteria up front, perform field-level reconciliation between source and target, run sample-based and full-population checks, and document discrepancies and their resolution in a migration verification report. We follow MHRA GxP data integrity expectations and the ALCOA+ principles throughout, so the migrated case database is defensible. AI-assisted reconciliation accelerates anomaly detection without replacing the documented verification evidence.
Vault is a continuously updated SaaS product with general releases roughly twice a year, so validation cannot be a one-time event. We establish a release management process: for each release we review Veeva's release notes and validation package, perform a risk-based impact assessment on your configuration and integrations, execute targeted regression testing on affected functionality, and document the outcome. This keeps the system in a continuous state of control without re-validating everything each cycle. The approach is consistent with GAMP 5 and the CSA emphasis on focusing effort where change and risk are greatest, and it is captured in a periodic review and change-control SOP.
Yes, and this is an area of growing regulatory attention. Validating AI components requires controlling for the fact that model behavior can change with updates or prompts, so we apply version control, locked model snapshots where appropriate, comprehensive audit logging of prompts and outputs, and regression testing against representative case sets. We keep a human-in-the-loop for any AI output that affects a regulatory record, so the AI is a decision-support tool rather than an autonomous system. We align to emerging expectations including the FDA's draft guidance on AI in drug and biological product development and the risk-tiering of the EU AI Act, and we document the AI workflow as part of the overall validated system.
Inspection readiness means that, on request, you can produce a coherent, traceable evidence trail: the validation plan and summary, the requirements and their test evidence, the Part 11 and Annex 11 control matrix, the migration verification report, gateway qualification records, change-control and periodic-review history, and the supporting SOPs. We also help teams rehearse the narrative — who owns the system, how data integrity is assured, how releases are controlled, and how deviations are handled. Pharmacovigilance systems are inspected by the FDA, EMA, MHRA, and other authorities, so we build the package to satisfy the most demanding of them.
Timelines depend on scope. A focused validation for a single-product post-market configuration with one gateway can run in parallel with implementation over roughly 8-12 weeks. A full global deployment with Argus migration, multiple gateways, partner integrations, and AI workflows is a larger effort spanning several months, typically delivered in phases that align with the implementation milestones. Leveraging Veeva's supplier validation evidence and reusable templates compresses the timeline considerably versus building everything from scratch. We scope the validation effort to the risk and complexity of your configuration so you are neither under- nor over-documented.
Yes. Many clients retain us for ongoing validation and compliance support after go-live: release impact assessments and regression testing each cycle, periodic reviews, change-control execution, audit and inspection support, and validation of new integrations or AI workflows as they are added. This keeps the system continuously validated without burdening your internal team, and it means the people who know your configuration are ready when an inspector arrives. You can combine this with our broader managed services, and book a meeting to scope an ongoing compliance engagement.
Ready to Make Your Veeva Vault Safety System Inspection-Ready?
Ready to Make Your Veeva Vault Safety System Inspection-Ready? image

Ready to Make Your Veeva Vault Safety System Inspection-Ready?

Talk to IntuitionLabs about risk-based GAMP 5 validation, 21 CFR Part 11 and EU GVP compliance, and inspection readiness for Veeva Vault Safety.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.